Genic제닉
123330 · KOSDAQ · ₩123330 · 제닉
₩15,470▼ ₩400 (2.52%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩49B | ₩29B | ₩12B | ₩24B | ₩25B | ₩18B | ₩19B | ₩15B |
| Cost of sales | ₩37B | ₩24B | ₩9.9B | ₩16B | ₩17B | ₩13B | ₩14B | ₩11B |
| Gross profit | ₩12B | ₩5.6B | ₩2.3B | ₩7.6B | ₩7.4B | ₩5.3B | ₩5.1B | ₩3.8B |
| Operating income | ₩10B | ₩3.4B | ₩104M | ₩5.6B | ₩5.5B | ₩3.8B | ₩3.6B | ₩2.1B |
| Net income | ₩7.7B | ₩3.5B | ₩14B | ₩1.3B | ₩484M | ₩3.5B | ₩5.7B | ₩1.1B |
| Net income to shareholders | ₩11B | ₩3.5B | ₩14B | ₩1.3B | ₩484M | ₩3.5B | ₩5.7B | ₩1.1B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩91B | ₩67B | ₩57B | ₩50B | ₩50B | ₩42B | ₩38B | ₩32B |
| Current assets | ₩60B | ₩39B | ₩31B | ₩33B | ₩34B | ₩24B | ₩21B | ₩19B |
| Cash and equivalents | ₩3.7B | ₩5.3B | ₩13B | ₩12B | ₩7.6B | ₩5.6B | ₩1.3B | ₩403M |
| Total liabilities | ₩35B | ₩22B | ₩15B | ₩15B | ₩20B | ₩16B | ₩16B | ₩16B |
| Current liabilities | ₩33B | ₩20B | ₩13B | ₩14B | ₩20B | ₩15B | ₩15B | ₩16B |
| Borrowings | ₩3B | ₩1.5B | ₩2.2B | ₩5B | ₩5B | ₩5B | ₩5B | ₩5B |
| Total equity | ₩56B | ₩45B | ₩41B | ₩35B | ₩30B | ₩26B | ₩22B | ₩17B |
| Shareholders' equity | ₩56B | ₩45B | ₩41B | ₩35B | ₩30B | ₩26B | ₩22B | ₩17B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩1.4B | −₩5.5B | ₩7.7B | ₩5.6B | ₩2.8B | ₩4.6B | ₩1.8B | −₩364M |
| Capital spending | ₩3B | ₩2.3B | ₩945M | ₩1B | ₩620M | ₩99M | ₩896M | ₩649M |
| Free cash flow | −₩4.5B | −₩7.8B | ₩6.8B | ₩4.6B | ₩2.1B | ₩4.5B | ₩892M | −₩1B |
Consolidated where available. Amounts in won.
Also known as: Genic / 제닉 / 123330 / KRX:123330
Source: KRX statistical information